Login to Your Account



Clinic Roundup


Thursday, July 11, 2013
• Inovio Pharmaceuticals Inc., of Blue Bell, Pa., published results from two Phase I trials of Pennvax-B vaccine for HIV delivered with a DNA adjuvant and with or without the Cellectra electroporation delivery device.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription